Tendersinfo Gulf

Filter Search

Europe

Location Summary Deadline
Germany Open House Drug Discount Agreements Tocilizumab, Atc L04ac07 2026-11-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Rotigotine, (obg) Atc N04bc09 For The Period 01.01.2025 31.12.2026 2026-11-05
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Allergen Extract From Tree Pollen (exclusively In The Dafo Pump Solution), Atc V01aa05 F. D. Z. 01.01.25 31.12.26 2026-11-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Security Code (sgb V) For The Active Ingredient Apremilast, (obo) Atc L04aa32 For The Period 01.01.2025 - 31.12.2026 2026-11-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Sgb V For The Active Ingredient Sevelamer Hydrochloride, (obg) Atc V03ae02 For The Period 01.01.2025 - 31.12.2026 2026-11-05
Germany Drug Discount Agreements Pursuant To Section 130a Para. 8 Sgb V Within The Framework Of Open House Procedures - Drug 2026-11-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Security Code (sgb V) For The Active Ingredient Allergen Extract From Tree Pollen (exclusively In The Dafo Pump Solution), Atc V01aa05 For The Period From 2026-11-05
Lithuania (2022-dps-2) 40-630 Kva 10/0.4 Kv Voltage Three-phase Oil Power Transformers 2026-11-07
Denmark Market Dialogue Concerning The Purchase Of An It Application To Support The Collection And Exchange Of Data Between Denmark And Other Eu Members According To The Council Directive (eu) 2023/2226 2026-11-07
Denmark Market Dialogue Regarding Dac8 2026-11-07
Whats app